Abhishek Ingole
Dr, Department of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Sawangi, Wardha, Maharashtra, IndiaPublications
-
Review Article
Prevalence and Infectivity of Asymptomatic COVID-19 Illness
Author(s): Rudra Rajesh Nair, Abhishek Ingole* and Ashok Mehendale
The Severe Acute Respiratory Syndrome Corona Virus 2 is a novel coronavirus (SARS-CoV-2), triggered a coronavirus disease outbreak in December 2019. Acute respiratory distress syndrome, acute renal failure, acute respiratory injury, septic shock, and severe pneumonia are all manifestations of acute respiratory distress syndrome that have all been recorded in 33% of patients who have received COVID-19. COVID-19 has no specific medication or vaccine that has been approved, and several clinical trials are now studying potential COVID-19 treatments. Some carcinoma patients' immunosuppression (either induced by the disease or treatment) makes them more susceptible to infection. Presently, extensive studies and efforts are done to understand the how the infection occurs and how to treat covid, but risk factors, the prognosis and outcomes after treatment are yet to be un.. Read More»